¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"apolipoprotein content"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apolipoprotein
    ¾ÆÆ÷ÁöÁú´Ü¹éÁú
  • content
    1. ³»¿ë 2. ÇÔ·®
  • content validity
    ³»¿ëŸ´ç¼º
  • chloride content
    ¿°¼Ò·®
  • gas content
    °¡½ºÇÔ·®
  • latent content
    ÀáÀç³»¿ë
  • manifest content
    ¹ßÇö³»¿ë
  • mean venous oxygen content
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®
  • oxygen content
    »ê¼ÒÇÔÀ¯·®
  • water content
    ¼öºÐÇÔ·®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • content
    ³»¿ë, ÇÔ·®
  • oxygen content
    »ê¼ÒÇÔÀ¯·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apolipoprotein
    ¾ÆÆ÷Áö¹æ´Ü¹é
  • content
    ³»¿ë, ÇÔ·®
  • chloride content
    ¿°¼Ò·®
  • content validity
    ³»¿ëŸ´ç¼º
  • gas content
    °¡½ºÇÔ·®
  • latent content
    ÀáÀç³»¿ë
  • manifest content
    ¹ßÇö³»¿ë
  • mean venous oxygen content
    Æò±ÕÁ¤¸ÆÇ÷»ê¼Ò·®
  • oxygen content
    »ê¼ÒÇÔÀ¯·®
  • water content
    ¼öºÐÇÔ·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apolipoprotein content
    ¾ÆÆ÷Áö´Ü¹éÇÔ·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GC content
    GCÇÔ·®
  • arterial oxygen content
    µ¿¸ÆÇ÷»ê¼ÒÇÔÀ¯·®
  • arterial-venous oxygen content difference
    µ¿¸Æ-Á¤¸Æ»ê¼Ò¿ëÀûÂ÷ÀÌ
  • arteriovenous oxygen content difference
    µ¿Á¤¸ÆÇ÷ »ê¼ÒÇÔ·®Â÷
  • ash content
    ȸºÐ(üéÝÂ).
  • gas content
    °¡½ºÇÔ·®.
  • heat content
    ÇÔ¿­·®(̰ËçËâ).
  • hemoglobin content/concentration
    Ç÷»ö¼ÒÇÔ·®/³óµµ
  • hernia content
    Ç츣´Ï¾Æ³»¿ë(¡­³»¿ë).
  • apolipoprotein
    ¾ÆÆ÷Áö¹æ´Ü¹é
  • apolipoprotein
    ¾ÆÆ÷Áö´Ü¹é
  • apolipoprotein A
    ¾ÆÆ÷Áö´Ü¹éA
  • apolipoprotein A-1
    ¾ÆÆ÷Áö´Ü¹é A-I
  • apolipoprotein B
    ¾ÆÆ÷Áö´Ü¹é B
  • apolipoprotein B-100
    ¾ÆÆ÷Áö´Ü¹é B-100
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apolipoprotein content
    ¾ÆÆ÷Áö´Ü¹éÇÔ·®
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apolipoprotein
    ¾ÆÆ÷Áö¹æ´Ü¹é
  • apolipoprotein
    ¾ÆÆ÷Áö´Ü¹é
  • apolipoprotein A
    ¾ÆÆ÷Áö´Ü¹éA
  • apolipoprotein A-1
    ¾ÆÆ÷Áö´Ü¹é A-I
  • apolipoprotein B
    ¾ÆÆ÷Áö´Ü¹é B
  • apolipoprotein B-100
    ¾ÆÆ÷Áö´Ü¹é B-100
  • apolipoprotein B-48
    ¾ÆÆ÷Áö´Ü¹é B-48
  • apolipoprotein C
    ¾ÆÆ÷Áö´Ü¹é C
  • apolipoprotein C-I
    ¾ÆÆ÷Áö´Ü¹é C-I
  • apolipoprotein C-II
    ¾ÆÆ÷Áö´Ü¹é C-II
  • apolipoprotein C-III
    ¾ÆÆ÷Áö´Ü¹é C-III
  • apolipoprotein C-Il deficiency
    ¾ÆÆ÷Áö´Ü¹é C-II °áÇÌ
  • apolipoprotein D
    ¾ÆÆ÷Áö´Ü¹é D
  • apolipoprotein E
    ¾ÆÆ÷Áö´Ü¹é E
  • apolipoprotein b, deficiency
    ¾ÆÆ÷¸®Æ÷´Ü¹éB°áÇÌÁõ(¡­Ó±ÛÜ¡­ÌÀù¹ñø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AT content
    ATÇÔ·® (ùßÕá)
  • GC content
    GC ÇÔ·®(ùßÕá)
  • heat content
    ¿­ÇÔ·®(æðùßÕá)
  • helical content
    ³ª¼± ÇÔ·®(Õ¢àÁùßÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • content
    ³»¿ë, ÇÔ·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APO abductor pollicis obliguus; acquired pendular oscillation; adriamycin, prednisone, vincristine; adve...
Apo, apo apolipoprotein
APOA, apoA apolipoprotein A
APOB, apoB apolipoprotein B
APOC, apoC apolipoprotein C
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CaO2 Arterial O2 content
BMC Bone Mineral Content
BMC, g Bone mineral content
BMD Bone mineral content and density
BMC Bone mineral density and content
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • clear content
    ±ú²ýÇÑ ÇÔÀ¯¹°
  • color content
    »ö °­µµ
  • curdlike content
    ÀÀÀ¯ °°Àº ³»¿ë¹°
  • cyst content
    ³¶Á¾ ÇÔÀ¯¹°
  • manifest content
    ¹ßÇö³»
  • moisture content
    ÇÔ¼ö·®, ÇÔ½Àµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
AT content <molecular biology> The percentage of nitrogenous bases on a DNA molecule which are either adenine or thymine (from a possibility of four different ones, also including cytosine and guanine).
See: GC content.
(09 Oct 1997)
carbon dioxide content The total carbon dioxide available from serum or plasma following addition of acid; measured routinely in hospital laboratories as a component of electrolyte profiles.
(05 Mar 2000)
GC content <molecular biology> The percentage of nitrogenous bases on a DNA molecule which are either guanine or cytosine (from a possibility of four different ones, also including adenine and thymine).
See: AT content.
(20 Mar 1998)
manifest content Those elements of fantasy and dreams which are consciously available and reportable.
(05 Mar 2000)
moisture content (MC) The weight of the water contained in wood, usually expressed as a percentage of weight, either oven-dry or as received.
(05 Dec 1998)
content 1. That which is contained within something else, usually in this sense in the plural form, contents.
2. In psychology, the form of a dream as presented to consciousness.
3. Ambiguous usage for concentration; e.g., blood haemoglobin content could mean either its concentration or the product of its concentration and the blood volume.
Origin: L. Contentus, fr. Con-tineo, pp. -tentus, to hold together, contain
(05 Mar 2000)
content analysis Any of a variety of techniques for classification and study of the verbal products of normal or of psychologically disabled individuals.
(05 Mar 2000)
content validity The extent to which the items of a test or procedure are in fact a representative sample of that which is to be measured; e.g., items relating to ability in arithmetic and defining words are appropriate content for an intelligence test.
(05 Mar 2000)
latent content The hidden, unconscious meaning of thoughts or actions, especially in dreams or fantasies.
(05 Mar 2000)
apolipoprotein <biochemistry, protein> The protein component of serum lipoproteins. Small proteins containing multiple copies of the kringle domain.
(18 Nov 1997)
apolipoprotein A-I <biochemistry> The major protein component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolised and excreted from the body. The compound is the activator of lecithin-cholesterol acyltransferase which forms cholesteryl esters in hdl. The gene for this apolipoprotein is found on the long arm of chromosome 11.
(12 Dec 1998)
apolipoprotein A-II <biochemistry> A component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolised and excreted from the body. This protein modulates the activation of lecithin-cholesterol acyltransferase in the presence of apolipoprotein A-I.
(12 Dec 1998)
apolipoprotein A-IV <biochemistry> An apolipoprotein secreted with chylomicrons.
(05 Mar 2000)
apolipoprotein B <biochemistry> Apolipoproteins found in LDL, VLDL, and IDL. Elevated in the plasma of individuals with familial hyperlipoproteinaemia.
(05 Mar 2000)
apolipoprotein B-100 <biochemistry> An apolipoprotein found in LDL, VLDL, and IDL. The ligand for the LDL receptor; absent in certain types of abetalipoproteinaemia.
Apolipoproteins are proteins on the surface of the lipoprotein complex that bind to specific enzymes or transport proteins across the cell membrane.
The normal range is 40 to 125 mg/dl.
Elevated levels may be seen in familial combined hyperlipidaemia and acquired hyperlipidaemia. Elevation may also be seen in cases of acute angina and myocardial infarction.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • content
    1:¾Ë¸ÍÀÌ,³»¿ë¹°,ÃëÁö,¿äÁö,ÇÔÀ¯·® 2:¸¸Á·Çϰí,´Þ°©°Ô¿©±â°í
  • well-content
    ¸Å¿ì ¸¸Á·ÇÑ
  • content
    ¼Ó¾Ë¸ÍÀÌ;³»¿ë¹°;(¼­Àû,¹®¼­µîÀÇ)³»¿ë;Â÷·Ê;¸ñÂ÷;³»¿ë;(Çü½Ä¿¡ ´ëÇÏ¿©)³»¿ë;ÃëÁö;¿äÁö;ÁøÀÇ;°³³äÀÇ ³»¿ë;¹ÝÀÀ ³»¿ë;ÇÔÀ¯·®;»êÃâ·®;¿ë·®;¿ëÀû;¸éÀû
  • content
    ¸¸Á·ÇÏ¿©;Âù¼ºÇÏ¿©;¸¸Á·;Âù¼ºÅõÇ¥;¸¸Á·À»ÁÖ´Ù;¸¸Á·½ÃŰ´Ù;...¿¡¸¸Á·ÇÏ´Ù;~less
  • content analysis
    ³»¿ë ºÐ¼®
  • content subject
    ³»¿ë°ú¸ñ(½Ç¿ë°ú¸ñ°ú ´ëÁ¶ÇÏ¿© öÇÐ.¿ª»çµî ±× ÀÚü¸¦ ¸ñÀûÀ¸·ÎÇϴ±³°ú,cf.TOOL
  • content word
    ³»¿ë¾î(½ÇÁúÀû ÀÇ¹Ì ³»¿ëÀ» °¡Áø ³¹¸»);(cf.FUNCTION WORD)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á